Michael Haude

2017 ESC/EACTS Guidelines for the management of valvular heart disease

Helmut Baumgartner, Volkmar Falk, Jeroen J. Bax et al. · European Heart Journal · 2017 · 6.3K citations · Full text

Medicine, Cardiology, Surgery +14

Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial

Raimund Erbel, Carlo Di Mario, Jozef Bartúnek et al. · The Lancet · 2007 · 901 citations

Medicine, Cardiology, Surgery +14

Contemporary Presentation and Management of Valvular Heart Disease

Bernard Iung, Victoria Delgado, Raphaël Rosenhek et al. · Circulation · 2019 · 587 citations · Full text

Medicine, Cardiology, Surgery +14

A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial

Patrick W. Serruys, Bernard Chevalier, Dariusz Dudek et al. · The Lancet · 2014 · 560 citations · Full text

Medicine, Cardiology, Surgery +17

Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 year, randomised, controlled, single-blind, multicentre clinical trial

Patrick W. Serruys, Bernard Chevalier, Yohei Sotomi et al. · The Lancet · 2016 · 538 citations · Full text

Medicine, Cardiology, Surgery +17